Who Paid My Doc
Defiance - Clottriever Thrombectomy System VS. Anticoagulation Alone for Treatment of Deep Vein Thrombosis
ClinicalTrials.gov NCT05701917
Research payments
$1,021,619
Through program year 2025, $1,021,619 in research payments was reported against Defiance - Clottriever Thrombectomy System VS. Anticoagulation Alone for Treatment of Deep Vein Thrombosis, across 667 payments.
- Paid by (largest first)
- Inari Medical, Inc.; Stryker Corporation
- ClinicalTrials.gov
- NCT05701917
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $429,165 | 297 |
| 2024 | Research | $592,454 | 370 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Abdullah Shaikh Pittsburgh, PA Named on 138 payments
- Peter Burke Lansing, MI Named on 111 payments
- Nicholas Mouawad West Branch, MI Named on 111 payments
- Venkataramanan Gangadharan Phoenix, AZ Named on 36 payments
- Alexander Hou Edgewood, KY Named on 24 payments
- Aravinda Nanjundappa Beckley, WV Named on 22 payments
- Justin Lee Tampa, FL Named on 20 payments
- Hamid Mojibian New Haven, CT Named on 20 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.